Company Search:
Advanced Search
Sponsored Links
Portola Pharmaceuticals Inc Company Snapshot
Portola Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Portola Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Nektar Therapeutics (2019 sales of $114.62 million of which 100% was Research and Product Sales), Agios Pharmaceuticals Inc ($117.91 million of which 100% was Bio-Pharmaceutical), and Ligand Pharmaceuticals Inc ($120.28 million of which 100% was Development & Licensing Biopharmaceutica).

Sales Analysis. Sales increased substantially in 2019: During the year ended December of 2019, sales at Portola Pharmaceuticals Inc were $116.64 million. This is an increase of 190.7% versus 2018, when the company's sales were $40.13 million.
  Stock Performance Chart for Portola Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/1/2020): 18.03
(Figures in U.S. Dollars)
1 Week 0.3%   13 Weeks 0.7%  
4 Weeks 179.5%   52 Weeks -31.7%  
Portola Pharmaceuticals Inc Key Data:
  Ticker: PTLA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 116,640,000
(Year Ending Jan 2020).
Employees: 408
  Currency: U.S. Dollars Market Cap: 1,415,066,520
  Fiscal Yr Ends: December Shares Outstanding: 78,484,000
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.